77 related articles for article (PubMed ID: 1805420)
21. [The use of Ticlid in treating cerebrovascular diseases].
Gusev EI; Skvortsova VI; Kolesnikova TI; Kabanov AA; Iasamanova AN
Ter Arkh; 1996; 68(10):69-72. PubMed ID: 9026951
[No Abstract] [Full Text] [Related]
22. [The prognosis and control of the efficacy of heparin therapy in patients with diabetic glomerulosclerosis].
Pyrig LA; Lapchinskaia II; Belitskaia GA; Lezhen TI; Iakovenko AM; Ishchenko VM; Fedorova NE
Klin Med (Mosk); 1996; 74(2):32-5. PubMed ID: 8772099
[TBL] [Abstract][Full Text] [Related]
23. [Comparative efficacy of tiklid and aspirin in patients with unstable angina].
Rebrov AP; Voskoboĭ IV
Ter Arkh; 2001; 73(12):25-9. PubMed ID: 11858103
[TBL] [Abstract][Full Text] [Related]
24. Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
Angiolillo DJ; Capranzano P; Desai B; Shoemaker SB; Charlton R; Zenni MM; Guzman LA; Bass TA
Thromb Res; 2009 Jul; 124(3):318-22. PubMed ID: 19012950
[TBL] [Abstract][Full Text] [Related]
25. [Diabeton in the treatment of stage I nephroangiopathy in insulin-dependent diabetes mellitus].
Kashirina EP; Bryzgalina SM; Balabolkin MI
Sov Med; 1991; (1):68-9. PubMed ID: 1862390
[No Abstract] [Full Text] [Related]
26. [The correction of intravascular microcoagulation of the blood].
Iena IaM
Lik Sprava; 1996; (1-2):20-6. PubMed ID: 9005097
[No Abstract] [Full Text] [Related]
27. [The effect of diabeton and metformin on the free-radical oxidation processes and the structural characteristics of the phospholipid composition of the erythrocyte membranes in non-insulin-dependent diabetes mellitus].
Buĭdina TA; Kozlov GS; Balabolkin MI
Sov Med; 1991; (7):14-6. PubMed ID: 1948331
[TBL] [Abstract][Full Text] [Related]
28. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
Swidan SZ; Montgomery PA
Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
[TBL] [Abstract][Full Text] [Related]
29. [Experience with diamicron treatment of diabetics].
Velikov VK; Shubina IO; Saltykov BB; Frolova AI
Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
[No Abstract] [Full Text] [Related]
30. Antiplatelet therapy in type 2 diabetes mellitus.
Angiolillo DJ
Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430
[TBL] [Abstract][Full Text] [Related]
31. [Disseminated intravascular coagulation syndrome (DIC) in stomach and intestinal cancer].
Pavlovskiĭ DP
Vopr Onkol; 1986; 32(2):37-42. PubMed ID: 3485857
[TBL] [Abstract][Full Text] [Related]
32. [Several aspects of the pathogenesis of disturbances of hemostasis in patients with diffuse toxic goiter].
Oleĭnik VA; Matiashina GI
Ter Arkh; 1988; 60(9):43-6. PubMed ID: 3217879
[TBL] [Abstract][Full Text] [Related]
33. [Correction of the disturbed coagulation circadian rhythm in patients with type 1 diabetes mellitus treated by aspirin chronotherapy].
Zaslavskaia RM; Tulemisov EU
Klin Med (Mosk); 2008; 86(10):17-23. PubMed ID: 19069453
[TBL] [Abstract][Full Text] [Related]
34. [The hemostasis system in diabetic retinopathy].
Sokolov EI; Balabolkin MI; Baluda MV; Morozova IP; Katsnel'son LA
Sov Med; 1985; (11):13-6. PubMed ID: 4089634
[No Abstract] [Full Text] [Related]
35. [The efficacy of ticlid in treating intermittent claudication in atherosclerotic stenosis of the arteries of the lower extremities].
Kirichenko AA; Prekina VI; Repinskaia NP; Novichkova IuN; Ter-Gevondian NM; Vinogradova IV
Ter Arkh; 1994; 66(12):23-6. PubMed ID: 7900036
[TBL] [Abstract][Full Text] [Related]
36. [Interrelations of trypsin-type serine proteases with the hemostatic system in diabetics].
Vaniurikhina LT; Orlova AV; Chernobyl'skaia LM
Vrach Delo; 1989 Jul; (7):88-90. PubMed ID: 2800517
[TBL] [Abstract][Full Text] [Related]
37. [The mechanisms of intravascular blood coagulation in patients with systemic scleroderma].
Diubanova GA; Sidorova LD; Barkagan LZ; Movchan EA; Valentik MF
Ter Arkh; 1990; 62(5):63-6. PubMed ID: 2396220
[TBL] [Abstract][Full Text] [Related]
38. [Fibrinogen-fibrin degradation products in diabetes mellitus].
Alakhverdian R; Koev D
Vutr Boles; 1987; 26(6):72-5. PubMed ID: 3125689
[TBL] [Abstract][Full Text] [Related]
39. [Diabetes mellitus and platelet half-life].
Banfi L; Vecchi C; Galetti A; Giussani R; Guzzini F
Clin Ter; 1987 May; 121(4):305-10. PubMed ID: 2973867
[No Abstract] [Full Text] [Related]
40. [Advantages and shortcomings of platelet antiaggregants in the treatment of myocardial infarction].
Nechaev DD; Bochko II; Martynov IV; Kuz'mina LF
Ter Arkh; 1988; 60(8):59-63. PubMed ID: 2976211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
